U.S. Hospitality Stock News

NYSE:JKS
NYSE:JKSSemiconductor

Is JinkoSolar (JKS) Offering Value After Recent Share Price Volatility And Cash Flow Outlook

If you are wondering whether JinkoSolar Holding’s current share price gives you good value, this article will walk through what the numbers actually say about the stock. The share price closed at US$25.81 most recently, with returns of 1.4% over the past week, a 1.9% decline over the past month, a 7.6% decline year to date, and a 30.8% gain over the last year, while the 3 year and 5 year returns are 45.1% and 50.4% declines respectively. Recent interest in solar and semiconductor related...
NasdaqGS:NDAQ
NasdaqGS:NDAQCapital Markets

Nasdaq (NDAQ) Margin Jump To 21.8% Tests High Valuation Narratives

NasdaqGS:NDAQ just closed out FY 2025 with fourth quarter revenue of US$2.1b and basic EPS of US$0.18, alongside trailing twelve month revenue of US$8.2b and EPS of US$1.56 that frame the full year picture. The company has seen revenue move from US$7.4b to US$8.2b over the latest trailing periods, with trailing EPS shifting from US$1.94 to US$1.56. This gives investors a clear read on how the top line and per share earnings have tracked into this result. With net profit margin running at...
NasdaqGS:TOWN
NasdaqGS:TOWNBanks

TowneBank (TOWN) Net Interest Margin Gain Tests Bullish Earnings Narratives

TowneBank (TOWN) has wrapped up FY 2025 with fourth quarter total revenue of US$220.1 million and basic EPS of US$0.52, alongside trailing twelve month revenue of US$811.8 million and EPS of US$2.22, setting the tone for how you might read the latest print. Over the past few quarters, total revenue has moved from US$175.6 million in Q4 2024 to US$220.1 million in Q4 2025, while quarterly EPS shifted from US$0.55 to US$0.52. These figures now sit against a trailing twelve month net income of...
NYSE:KOS
NYSE:KOSOil and Gas

Is Kosmos Energy’s (KOS) Tender Offer Extension Reframing Its Balance Sheet Strategy or Just Tinkering?

Kosmos Energy recently extended, in the past, the early tender and withdrawal deadlines for its cash offer to repurchase up to US$250 million of its 7.750% Senior Notes due 2027, giving bondholders more time to participate while still receiving total consideration. This extension highlights Kosmos Energy’s ongoing liability management efforts, which could influence the timing and composition of its balance sheet and future financing flexibility. Next, we’ll examine how extending the senior...
NasdaqGS:DRH
NasdaqGS:DRHHotel and Resort REITs

A Look At DiamondRock Hospitality (DRH) Valuation After Fresh Optimism From Deutsche Bank And Morgan Stanley

Analyst sentiment puts DiamondRock Hospitality in focus Recent analyst moves at Deutsche Bank and Morgan Stanley have put DiamondRock Hospitality (DRH) back on investor radar, as both firms highlighted the hotel REIT’s positioning in what they view as resilient lodging markets. See our latest analysis for DiamondRock Hospitality. At a share price of US$9.19, DiamondRock’s recent moves tell a mixed story, with a 1 day share price return of 1.66% and a 7 day share price return of a 4.27%...
NYSE:FHI
NYSE:FHICapital Markets

Federated Hermes Hong Kong Move Puts Asia Growth And Valuation In Focus

Federated Hermes, NYSE:FHI, has received board approval to establish a new office in Hong Kong. The expansion is aimed at serving major financial institutions across Asia more directly. The move marks a material shift in the company’s geographic footprint beyond its existing bases. Federated Hermes, trading at $53.03, is extending its reach into Asia with a Hong Kong office aimed at deepening relationships with large financial institutions. The company has delivered a 37.4% return over the...
NasdaqGS:CCB
NasdaqGS:CCBBanks

Coastal Financial CEO Share Sale Spurs Fresh Look At Growth Versus Risks

Coastal Financial CEO executes an open market sale of company shares under a Rule 10b5-1 trading plan. The transaction involves pre arranged selling activity by an insider at NasdaqGS:CCB. The move attracts attention as investors review what it may signal about leadership and capital allocation. For context, Coastal Financial, trading on NasdaqGS:CCB, last closed at $100.81. The stock has seen a 12.1% gain over the past year, alongside very large returns over the past 5 years. More...
NYSE:FIG
NYSE:FIGSoftware

Is Figma (FIG) Pricing Still Justified After Recent 28% Slide In The Share Price

If you are wondering whether Figma's share price lines up with its real worth, this article will walk through what the numbers are actually saying about valuation. The stock last closed at US$27.07, with returns of a 4.8% decline over 7 days and a 28.1% decline over 30 days, which may have changed how some investors see its risk and potential reward. Recent coverage around Figma has focused on its position in collaborative design software and how investors are weighing that against the...
NYSE:HZO
NYSE:HZOSpecialty Retail

MarineMax (HZO) Q1 Loss Deepens YoY And Tests Turnaround Bullish Narratives

MarineMax (HZO) opened Q1 2026 with revenue of US$505.2 million and a basic EPS loss of US$0.36, compared with Q1 2025 revenue of US$468.5 million and EPS of US$0.80. Over the intervening quarters, revenue ranged between roughly US$552 million and US$657.2 million. EPS moved from a profit of US$0.15 in Q2 2025 to a larger loss of US$2.42 in Q3 2025, keeping margin pressure firmly in focus for investors trying to make sense of the latest print. See our full analysis for MarineMax. With the...
NasdaqGS:ABCL
NasdaqGS:ABCLLife Sciences

AbCellera Advances ABCL635 Menopause Candidate As Shares Trade Below Targets

AbCellera Biologics (NasdaqGS:ABCL) has begun dosing patients in the Phase 2 portion of its Phase 1/2 clinical trial for ABCL635. ABCL635 is a non hormonal candidate for treating moderate to severe vasomotor symptoms associated with menopause. This Phase 2 dosing milestone marks further clinical progress in the company's efforts to develop a potential first in class menopause therapy. AbCellera Biologics, known for its antibody discovery platform, is pushing deeper into clinical development...
NasdaqGS:TFSL
NasdaqGS:TFSLBanks

Can TFS Financial’s Margin and Cost Pressures Recast Its Profit Story for Investors in TFSL?

TFS Financial Corporation recently reported past first-quarter results for the period ended December 31, 2025, with net interest income rising to US$75.68 million while net income held roughly steady at US$22.27 million, or US$0.08 per share. Beneath the stable earnings per share, the company is contending with pressure on net interest margins and higher non-interest costs linked to bonuses, marketing, and technology spending, even as management points to strong capital and credit...
NYSE:WGO
NYSE:WGOAuto

Is Winnebago Industries (WGO) Pricing Too Rich After Its Recent 30% Monthly Jump

If you are wondering whether Winnebago Industries is a bargain or a value trap at around US$46.65 per share, this breakdown will help you frame that question with actual numbers. The stock is roughly flat over the last year with a 0.2% return. It shows a 13.4% gain over the past 30 days and a 3.8% decline over the last week, alongside longer term 3 year and 5 year returns of 25.8% and 25.4% declines. Recent moves in the share price sit against a backdrop of ongoing interest in RV and outdoor...
NasdaqGM:NRIX
NasdaqGM:NRIXBiotechs

Nurix Therapeutics (NRIX) Q4 Loss Highlights Ongoing Profitability Concerns Despite Revenue Progress

Nurix Therapeutics (NRIX) closed out FY 2025 with Q4 revenue of US$13.6 million and a basic EPS loss of US$0.82, while the trailing twelve months show revenue of US$84.0 million and a basic EPS loss of US$3.05. Over recent periods, the company has seen quarterly revenue range from US$7.9 million to US$44.1 million and basic EPS losses move between US$0.52 and US$1.03 per quarter. This sets the backdrop for what remains an early stage, loss making biotech story. For investors, the key question...
NasdaqGS:EXTR
NasdaqGS:EXTRCommunications

Is Extreme Networks (EXTR) Attractive After Recent Share Price Weakness?

Wondering whether Extreme Networks is priced attractively today or if the recent share moves are a warning sign? This article focuses squarely on what you are getting for the current price. The stock last closed at US$14.37, with returns of a 5.4% decline over the past week, a 14.9% decline over the last month, and a 13.1% decline year to date. The 1 year return is a 7.9% decline and the 3 year return is a 23.6% decline, compared with a 5 year return of 61.1%. Recent attention around Extreme...
NasdaqGS:ZD
NasdaqGS:ZDInteractive Media and Services

Ziff Davis Taps AI In Unified RetailMeNot Group To Deepen Engagement

Ziff Davis (NasdaqGS:ZD) has launched the unified RetailMeNot Group, bringing several of its shopping platforms under one banner. The new group introduces AI powered tools designed to improve the online shopping experience for consumers. This move reflects Ziff Davis's focus on digital retail and customer engagement through technology. Ziff Davis, through RetailMeNot Group, is leaning further into digital retail and online deal discovery, an area where consumer expectations for...
NYSE:BIP
NYSE:BIPIntegrated Utilities

Brookfield Infrastructure Partners (NYSE:BIP) Margin Rebound Tests High P/E Bullish Narratives

Brookfield Infrastructure Partners' FY 2025 Earnings Snapshot Brookfield Infrastructure Partners (NYSE:BIP) closed out FY 2025 with fourth quarter revenue of about US$6.3 billion, basic EPS of US$0.40 and net income of US$245 million, putting a spotlight on how its profitability is tracking against expectations. The company has seen revenue move from US$5.4 billion in Q4 2024 to roughly US$6.3 billion in Q4 2025, while basic EPS shifted from US$0.26 to US$0.40 over the same period. This gives...
NYSE:CNMD
NYSE:CNMDMedical Equipment

One Off US$88 Million Loss And Margin Compression Test CONMED (CNMD) Bullish Narratives

CONMED (CNMD) just wrapped up FY 2025 with Q4 revenue of US$373.2 million and basic EPS of US$0.54, alongside trailing twelve month revenue of about US$1.4 billion and EPS of US$1.52. Over the past six quarters in the dataset, revenue has ranged from US$316.7 million to US$373.2 million per quarter, while quarterly EPS has moved between US$0.09 and US$1.59. With trailing net margin sitting at 3.4% versus 10.1% a year earlier, this latest result puts a clear focus on how sustainable the...
NYSE:RCL
NYSE:RCLHospitality

Royal Caribbean Cruises (RCL) Margin Jump Reinforces Bullish Profitability Narratives

Royal Caribbean Cruises (RCL) has just posted its FY 2025 numbers, with fourth quarter revenue at US$4.3b and basic EPS of US$2.78, capping a trailing twelve month run of US$17.9b in revenue and US$15.75 in EPS. Over recent periods the company has seen quarterly revenue move from US$3.8b and EPS of US$2.05 in Q4 2024 to US$5.1b and EPS of US$5.79 in Q3 2025, before this latest quarter. This sets up the full year against a backdrop of faster earnings growth than revenue and meaningfully higher...
NasdaqCM:RGC
NasdaqCM:RGCPharmaceuticals

A Look At Regencell Bioscience Holdings (RGC) Valuation After Market Value Surges Despite Ongoing Challenges

Regencell Bioscience Holdings (RGC) is back in focus after recent coverage highlighted a sharp surge in its market value, despite having no revenue, recurring losses, and an ongoing Justice Department investigation. See our latest analysis for Regencell Bioscience Holdings. The share price has been volatile, with a 1 day share price return of a 13.61% decline and a 7 day share price return of a 9.34% decline. Despite this, it still sits on a 30 day share price return of 21.81% and a 90 day...
NYSE:VFC
NYSE:VFCLuxury

VF Corp (VFC) Q3 Profit Rebound Tests Valuation Concerns In Bullish Narratives

V.F. Corporation (VFC) just posted Q3 2026 results with revenue of US$2.9b and basic EPS of US$0.77, setting a clear reference point for how the year is shaping up. The company has seen quarterly revenue move from US$2.8b in Q2 2026 and US$2.9b in Q3 2025, while EPS shifted from US$0.49 in Q2 2026 and US$0.43 in Q3 2025, giving investors a clean view of how the income statement is trending as margins settle after a volatile period. See our full analysis for V.F. With the latest numbers on the...
NasdaqGS:KLAC
NasdaqGS:KLACSemiconductor

KLA Upgrades Highlight 2nm Inspection Demand And Recent Earnings Strength

Multiple major analysts upgraded KLA (NasdaqGS:KLAC), citing strong demand for advanced semiconductor inspection equipment and growth in 2nm process technology. KLA reported significantly improved quarterly financial results, with revenue and profit both moving higher. The combination of analyst upgrades and the latest earnings release has sharpened investor focus on KLA's role in next generation chip manufacturing. KLA enters this news cycle with its share price at $1,684.71 and a very...
NasdaqGS:CSGP
NasdaqGS:CSGPReal Estate

Third Point Escalates CoStar Battle Over Board And Residential Focus

Third Point has escalated its activist campaign at CoStar Group, pushing for a board overhaul and fresh directors at NasdaqGS:CSGP. The fund is urging CoStar to refocus on its core commercial real estate data business and consider divesting its residential real estate operations. Third Point has publicly criticized governance, strategy, and management compensation, framing its campaign as an effort to restore shareholder value. For shareholders, this fight comes after a challenging run for...